- Home
- GIFT vs DYAI Comparison
GIFT vs DYAI Comparison
Compare GIFT & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- DYAI
- Stock Information
- Founded
- GIFT 1999
- DYAI 1979
- Country
- GIFT United States
- DYAI United States
- Employees
- GIFT N/A
- DYAI N/A
- Industry
- GIFT Catalog/Specialty Distribution
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GIFT Consumer Discretionary
- DYAI Health Care
- Exchange
- GIFT Nasdaq
- DYAI Nasdaq
- Market Cap
- GIFT 53.3M
- DYAI 54.4M
- IPO Year
- GIFT N/A
- DYAI 2004
- Fundamental
- Price
- GIFT $1.74
- DYAI $1.18
- Analyst Decision
- GIFT Strong Buy
- DYAI Strong Buy
- Analyst Count
- GIFT 1
- DYAI 1
- Target Price
- GIFT $4.00
- DYAI $6.00
- AVG Volume (30 Days)
- GIFT 52.1K
- DYAI 23.0K
- Earning Date
- GIFT 05-15-2025
- DYAI 05-13-2025
- Dividend Yield
- GIFT N/A
- DYAI N/A
- EPS Growth
- GIFT N/A
- DYAI N/A
- EPS
- GIFT N/A
- DYAI N/A
- Revenue
- GIFT $88,934,036.00
- DYAI $3,495,389.00
- Revenue This Year
- GIFT $26.85
- DYAI $117.40
- Revenue Next Year
- GIFT $19.89
- DYAI N/A
- P/E Ratio
- GIFT N/A
- DYAI N/A
- Revenue Growth
- GIFT 2.05
- DYAI 20.58
- 52 Week Low
- GIFT $0.50
- DYAI $0.93
- 52 Week High
- GIFT $4.27
- DYAI $2.67
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- DYAI 36.48
- Support Level
- GIFT N/A
- DYAI $1.15
- Resistance Level
- GIFT N/A
- DYAI $1.25
- Average True Range (ATR)
- GIFT 0.00
- DYAI 0.07
- MACD
- GIFT 0.00
- DYAI 0.00
- Stochastic Oscillator
- GIFT 0.00
- DYAI 14.29
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About DYAI Dyadic International Inc.
Dyadic International Inc is a world-wide biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.